Continue to Site
Drug Discovery and Development
Home Drug Discovery and Development
Drug Discovery
Women in Pharma and Biotech
Oncology
Neurological Disease
Infectious Disease
Resources
Video features
Podcast
Webinars
Pharma 50
2023 Pharma 50
2022 Pharma 50
2021 Pharma 50
FibroGen, Inc.
By
FibroGen, Inc.
|
January 30, 2017
FibroGen’s Roxadustat Meets Primary Endpoints in Anemia Studies
Search Drug Discovery & Development
Home Drug Discovery and Development
Drug Discovery
Women in Pharma and Biotech
Oncology
Neurological Disease
Infectious Disease
Resources
Video features
Podcast
Webinars
Pharma 50
2023 Pharma 50
2022 Pharma 50
2021 Pharma 50
